Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.470
-0.030 (-2.00%)
Sep 4, 2026, 11:58 AM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 68.52 million as of September 3, 2026. Its market cap has decreased by -20.18% in one year.
Market Cap
68.52M
Enterprise Value
65.27M
Revenue
275.74K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.47
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 68.52M, a decrease of -52.54%. That is a compound annual growth rate of -13.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 67.61M | -22.01% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 132.71M |
| Biovica International AB | 131.36M |
| Nanologica AB | 123.95M |
| Annexin Pharmaceuticals AB | 94.24M |
| Spago Nanomedical AB | 89.82M |
| Ascelia Pharma AB | 84.26M |
| OncoZenge AB | 80.11M |
| AcouSort AB | 64.13M |